SC 13G/A: Voyager Therapeutics, Inc.

AI Summary

SC 13G/A filing by Voyager Therapeutics, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.001 — Inc. (Name of Issuer) COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class o

Filing Documents

• d791499dsc13ga.htm (SC 13G/A) — 92KB
• 0001193125-24-036268.txt ( ) — 93KB

From the Filing

SC 13G/A 1 d791499dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* Voyager Therapeutics, Inc. (Name of Issuer) COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 92915B106 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 92915B106 SCHEDULE 13G Page 2 of 9 Pages 1. NAMES OF REPORTING PERSONS Third Rock Ventures III, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% (1) 12. TYPE OF REPORTING PERSON PN (1) The percent of class was calculated based on 43,995,363 shares of common stock issued and outstanding as of October 30, 2023, as disclosed in the Issuers Prospectus Supplement filed with the Securities and Exchange Commission on November 6, 2023. CUSIP No. 92915B106 SCHEDULE 13G Page 3 of 9 Pages 1. NAMES OF REPORTING PERSONS Third Rock Ventures GP III, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% (1) 12. TYPE OF REPORTING PERSON PN CUSIP No. 92915B106 SCHEDULE 13G Page 4 of 9 Pages 1. NAMES OF REPORTING PERSONS TRV GP III, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% (1) 12. TYPE OF REPORTING PERSON OO CUSIP No. 92915B106 SCHEDULE 13G Page 5 of 9 Pages 1. NAMES OF REPORTING PERSONS Robert I. Tepper 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 186,423 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 186,423 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 186,423 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.4% (1) 12. TYPE OF REPORTING PERSON IN CUSIP No. 92915B106 SCHEDULE 13G Page 6 of 9 Pages Item1. Issuer (a) Name of Issuer: Voyager Therapeutics, Inc. (the Issuer ) (b) Address of Issuers Principal Executive Offices: 75 Hayden Avenue Lexington, MA 02421 Item2. Filing Person (a) (c) Name of Persons Filing; Address; Citizenship: (i)Third Rock Ventures III, L.P. ( TRV III ); (ii)Third Rock Ventures GP III, L.P. ( TRV GP III ), which is the sole general partner of TRV III; (iii)TRV GP III, LLC ( TRV GP III LLC ), which is the sole general partner of TRV GP III; and (iv)Robert I. Tepper ( Tepper , and collectively with TRV III, TRV GP III and TRV GP III LLC, the Reporting Persons ), the managing member of TRV GP III LLC. The address of the principal business office of each of the Reporting

View Full Filing

View this SC 13G/A filing on SEC EDGAR